Business
The Westaim Corporation announces filing of Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering of its NUCRYST Pharmaceuticals Corp. subsidiary
The Westaim Corporation announces filing of Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering of its NUCRYST Pharmaceuticals Corp. subsidiary.
About this update from Westaim Corporation
[{"type":"text","content":"\n\n\n\n\nCALGARY, Dec. 2 /CNW/ - The Westaim Corporation announced today that its\nsubsidiary NUCRYST Pharmaceuticals Corp. (\"NUCRYST\") has filed a registration\nstatement with the U.S. Securities and Exchange Commission and a preliminary\nprospectus with each of the Canadian provincial securities regulatory\nauthorities (other than Quebec) relating to the proposed initial public\noffering of NUCRYST's common shares. All of the shares to be sold in the\noffering will be newly issued shares sold by NUCRYST with Westaim retaining a\ncontrolling interest in NUCRYST.\nThe shares will be offered by an underwriting syndicate led by Jefferies\n& Company, Inc. and co-managed by Adams Harkness, Inc., GMP Securities L.P.,\nand SunTrust Capital Markets, Inc.\nA registration statement relating to these securities has been filed with\nthe U.S. Securities and Exchange Commission but has not yet become effective.\nA preliminary prospectus relating to these securities has been filed with each\nof the Canadian provincial securities regulatory authorities (other than\nQuebec). These securities may not be sold nor may offers to buy be accepted in\nthe United States, prior to the time the registration statement becomes\neffective and in any province of Canada, prior to the time that a receipt for\na final prospectus is obtained from the securities commission or similar\nauthority in such province. This press release shall not constitute an offer\nto sell or a solicitation of an offer to buy, nor will there be any sale of\nthese securities in any state, province or jurisdiction in which such an\noffer, solicitation or sale would be unlawful prior to registration or\nqualification under the securities laws of such state, province or\njurisdiction. The offering will be made only by means of a prospectus.\nWhen available, copies of the preliminary prospectus relating to these\nsecurities may be obtained in the United States from Jefferies & Company by\nfax request at (212) 284-2208 and in Canada from GMP Securities L.P. by fax\nrequest at (416) 943-6133. When available, copies of the preliminary\nprospectus relating to these securities may also be obtained by mail request\nat the following addresses:\n\nJefferies & Company, Inc.\n520 Madison Avenue\n12th Floor\nNew York, NY\n10022\n\nGMP Securities L.P.\nAttn: Syndication Department\n145...